Soluble donor DNA and islet injury after transplantation

Transplantation

Volumn 92, Issue 5, 2011, Pages 607-611

  Gadi, Vijayakrishna K ^a,b   Nelson, J Lee ^a,b   Guthrie, Katherine A ^a   Anderson, Colin C ^c   Boespflug, Nicholas D ^a   Redinger, Jeffrey W ^a   Paul, Biswajit ^a   Dinyari, Parastoo ^c   Shapiro, A M James ^c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

DNA microchimerism; Islet cell transplantation; Quantitative PCR

Indexed keywords

C PEPTIDE; DNA; HLA ANTIGEN; INSULIN; SOLUBLE DONOR DNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRAFT DYSFUNCTION; HUMAN; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LIVING DONOR; MALE; PANCREAS ISLET ALLOGRAFT INJURY; PANCREAS ISLET TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DNA; FEMALE; GENOTYPE; HLA ANTIGENS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SOLUBILITY; TISSUE DONORS;

EID: 80052416359     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318228d799     Document Type: Article

References (15)

1. White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet 2009; 373: 1808.
2. Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet Transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
3. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginaldose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
4. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
5. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
6. Berney T, Mamin A, James Shapiro AM, et al. Detection of insulin mRNA in the peripheral blood after human islet transplantation predicts deterioration of metabolic control.AmJ Transplant 2006; 6: 1704.
7. Evgenov NV, Medarova Z, Dai G, et al. In vivo imaging of islet transplantation. Nat Med 2006; 12: 144.
8. Bennet W, Sundberg B, Groth CG, et al. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 1999; 48: 1907.
9. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005; 54: 1755.
10. Gadi VK, Nelson JL, Boespflug ND, et al. Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection. Clin Chem 2006; 52: 379.
11. Alejandro R, Barton FB, Hering BJ, et al. 2008 Update from the collaborative islet transplant registry. Transplantation 2008; 86: 1783.
12. Koh A, Senior P, Salam A, et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation 2010; 89: 465.
13. Berman DM, Cabrera O, Kenyon NM, et al. Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation 2007; 84: 308.
14. Ozmen L, Ekdahl KN, Elgue G, et al. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: Possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 2002; 51: 1779.
15. Cui W, Wilson JT, Wen J, et al. Thrombomodulin improves early outcomes after intraportal islet transplantation. Am J Transplant 2009; 9: 1308.